Vaccines: producing billions of doses remains a titanic challenge
After having developed their precious serums in record time, the laboratories face another major challenge.
In a few days, the first vaccines will be produced on French territory. The subcontractors Delpharm and Recipharm are in the starting blocks. Almost simultaneously, the production lines of their factories in Saint-Rémy-sur-Avre (Eure-et-Loir) and Monts (Indre-et-Loire) will start up in order to produce the vaccines of Pfizer / BioNTech and of Moderna, and the first deliveries of “made in France” doses should take place in April.
France is not alone in participating in the general mobilization. Vaccine factories around the world are at war. Because after having developed their precious serums in record time, the labs are facing another major challenge: to produce and distribute several billion doses to the whole world in just a few months. A titanic task. Pfizer / BioNTech has promised 2 billion doses in 2021 (against 1.3 billion initially). Moderna has pledged to deliver up to 1 billion. AstraZeneca,
This article is for subscribers only. You have 78% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
Already subscribed? Log in